Drug Discovery World

FEBRUARY 2, 2024

He says: “Then, maybe in 2025/2026, we’re ready to apply vast and dramatic AI models, because then we’ll have it.” Recently, the very first human in vivo CRISPR therapeutic was approved in the EU for sickle cell disease, by Vertex and by CRISPR Therapeutics.

Compliance 130

Compliance Science Pharma Companies Engineering 130

Drug Discovery World

OCTOBER 4, 2022

This year’s event will cover some of the most exciting advancements in areas spanning screening, automation, high content imaging, disease models, cell and gene therapies and how innovation is being driven through partnerships and collaborations. This year has seen some major deals announced by big pharma companies.

Drugs 130

Drugs Therapies Clinical Trials Cell Based Assays 130

Drug Discovery World

JANUARY 24, 2024

PW: The big challenge with fibrotic diseases is that they evolve slowly and are diagnosed late in the disease process. Only a few drugs have received approval for fibrotic diseases like IPF (idiopathic pulmonary fibrosis). The most crucial step in this process is the selection of the relevant disease markers.

Small Molecule 147

Small Molecule Research Pharma Companies Disease 147